New Human CD22/Siglec‐2 Ligands with a Triazole Glycoside
Sign Up to like & getrecommendations! Published in 2017 at "ChemBioChem"
DOI: 10.1002/cbic.201600707
Abstract: CD22 is a member of the Siglec family. Considerable attention has been drawn to the design and synthesis of new Siglec ligands to explore target biology and innovative therapies. In particular, CD22‐ligand‐targeted nanoparticles with therapeutic… read more here.
Keywords: new human; human cd22; cd22; cd22 siglec ... See more keywords